Literature DB >> 6387042

Polypeptide specificity of the early antibody response following primary and recurrent genital herpes simplex virus type 2 infections.

R Eberle, S W Mou, J A Zaia.   

Abstract

Relative IgG titres to specific viral proteins in acute and convalescent sera from patients with primary and recurrent genital herpes simplex virus type 2 (HSV-2) infections were determined using an immunoblot assay. Patients with recurrent genital infections generally had high titres of antibody reactive with two of the three major viral glycoproteins (gD and gG) as well as with several viral capsid proteins in both acute and convalescent sera. In contrast, patients experiencing primary genital HSV-2 infections exhibited marked differences in the polypeptide reactivity profiles of acute and convalescent sera. Of particular interest was the observation that the earliest and strongest antibody response was directed not against the viral glycoproteins but rather to an internal capsid protein(s) of HSV-2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387042     DOI: 10.1099/0022-1317-65-10-1839

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.

Authors:  H J Bernsen; A M Van Loon; R F Poels; W I Verhagen; C W Frenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

2.  Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.

Authors:  J Kahlon; F D Lakeman; M Ackermann; R J Whitley
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

3.  HSV-1 gB and VZV gp-II crossreactive antibodies in human sera.

Authors:  J E Kühn; K Klaffke; K Munk; R W Braun
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Serological evidence for variation in the incidence of herpesvirus infections in different species of apes.

Authors:  R Eberle; J K Hilliard
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

5.  Production of herpes B virus recombinant glycoproteins and evaluation of their diagnostic potential.

Authors:  Ludmila Perelygina; Irina Patrusheva; Soumya Hombaiah; Holley Zurkuhlen; Martin J Wildes; Nikolai Patrushev; Julia Hilliard
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

6.  Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.

Authors:  D W Ho; P R Field; W L Irving; D R Packham; A L Cunningham
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  An automated ELISA using recombinant antigens for serologic diagnosis of B virus infections in macaques.

Authors:  David Katz; Wei Shi; Irina Patrusheva; Ludmila Perelygina; Manjunath S Gowda; Peter W Krug; Chadi N Filfili; John A Ward; Julia K Hilliard
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

8.  Reassessing the detection of B-virus-specific serum antibodies.

Authors:  David Katz; Wei Shi; Martin J Wildes; Peter W Krug; Julia K Hilliard
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

Review 9.  The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines.

Authors:  Alireza Mardanshahi; Nasrin Abbasi Gharibkandi; Samaneh Vaseghi; Seyed Mohammad Abedi; Sajjad Molavipordanjani
Journal:  Mol Biol Rep       Date:  2021-08-06       Impact factor: 2.316

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.